<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anagnostopoulou, K</style></author><author><style face="normal" font="default" size="100%">Kolovou, G</style></author><author><style face="normal" font="default" size="100%">Kostakou, P</style></author><author><style face="normal" font="default" size="100%">Kolovou, V</style></author><author><style face="normal" font="default" size="100%">Stamatelatou, M</style></author><author><style face="normal" font="default" size="100%">C Mihas</style></author><author><style face="normal" font="default" size="100%">Vasiliadis, I</style></author><author><style face="normal" font="default" size="100%">Diakoumakou, O</style></author><author><style face="normal" font="default" size="100%">Mikhailidis, D</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">P827 PHARMACOGENETIC STUDY OF CHOLESTERYL ESTER TRANSFER PROTEIN GENE AND ATORVASTATIN TREATMENT IN HYPERCHOLESTEROLAEMIC SUBJECTS</style></title><secondary-title><style face="normal" font="default" size="100%">Atherosclerosis Supplements</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year></dates><number><style face="normal" font="default" size="100%">2</style></number><publisher><style face="normal" font="default" size="100%">Elsevier</style></publisher><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">e1217</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>